Featural and configural face processing differentially modulate ERP components.

Brain Research
Evelyne MercureM H Johnson

Abstract

Since all faces share the same first-order configuration, individual faces are recognized by subtle differences in their individual features and second-order configuration. This study asked two questions about the ERP signatures of featural and configural face processing. First, which ERP components are sensitive to subtle modifications of features and second-order configuration? Secondly, does explicitly instructing participants to attend to either the features or the configuration of face stimuli influence the neural processes elicited by these stimuli? In the first part of this experiment, pairs of faces with differences in their features, in their second-order configuration or no difference were presented, with participants making same/different judgments. In the second part, participants were asked to focus on either the features or configuration in pairs of faces and to judge if there was any difference in that aspect while ignoring other differences. The P1 and N170 ERP components were not influenced by feature or second-order configuration differences in faces, indicating that these components could be more sensitive to manipulations that disrupt the first-order configuration of a face. In contrast, the P2 was larger in...Continue Reading

References

May 1, 1993·Electroencephalography and Clinical Neurophysiology·T CurranM I Posner
Sep 1, 1993·Electroencephalography and Clinical Neurophysiology·D M Tucker
Apr 6, 2002·Psychological Science·Shlomo BentinYves D von Cramon
May 29, 2002·NeuroImage·Pamela MosesJoan Stiles
Jun 1, 2002·Trends in Cognitive Sciences·Daphne MaurerCatherine J. Mondloch
Jun 5, 2002·Perception·Catherine J MondlochDaphne Maurer
Feb 10, 2006·Brain and Cognition·Richard Le GrandDaphne Maurer
Jul 15, 2006·Journal of Cognitive Neuroscience·Eleni KotsoniMark H Johnson
Apr 25, 2007·Neuropsychologia·Eleni KotsoniMark H Johnson
Apr 5, 2008·Neuroreport·Johanna StahlStefan R Schweinberger
Nov 1, 1996·Journal of Cognitive Neuroscience·Shlomo BentinGregory McCarthy

❮ Previous
Next ❯

Citations

Jul 19, 2013·Biological Psychology·Holger WieseStefan R Schweinberger
May 21, 2009·Social Cognitive and Affective Neuroscience·Sara Jane WebbGeraldine Dawson
Jul 3, 2013·PloS One·Éva M BankóZoltán Vidnyánszky
Mar 12, 2013·Social Cognitive and Affective Neuroscience·Nicole WolffHolger Wiese
Jan 17, 2012·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Gabriel PiresMiguel Castelo-Branco
Jan 7, 2016·Frontiers in Human Neuroscience·Jing LvLun Zhao
Aug 8, 2015·Human Brain Mapping·David Beltrán, Manuel G Calvo
May 15, 2016·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Susan FajaSara Jane Webb
Feb 5, 2013·Vision Research·Zaira CattaneoClaus-Christian Carbon
May 6, 2014·Frontiers in Psychology·Kornél NémethMárta Zimmer
Aug 29, 2014·Journal of Integrative Neuroscience·Zhenhua LiuLun Zhao
May 8, 2018·Cognitive, Affective & Behavioral Neuroscience·Tamara RakićHolger Wiese
Mar 30, 2017·Frontiers in Psychology·Marcello NegriniDavide Rivolta
Feb 6, 2017·Perception·Hong ZhangLun Zhao
Mar 21, 2021·Social Neuroscience·Petra C Schmid, David M Amodio
Mar 23, 2021·Autism Research : Official Journal of the International Society for Autism Research·Termara C ParkerJames C McPartland
May 8, 2021·Brain and Behavior·Christian Valt, Birgit Stürmer
Sep 11, 2021·Journal of Experimental Child Psychology·Gizelle AnzuresElizabeth Soethe

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.